Dr. Mary Trinh Pentel, MD

Dr. Pentel practices at Southside Dermatology, P.A. in Jacksonville, Florida.

Dr. Pentel's NPI, 1588677058, was assigned on August 14, 2006. Dr. Pentel graduated from Penn State College of Medicine in 1994. Dr. Pentel holds Florida license ME76473.

Dr. Pentel's primary practice is Southside Dermatology, P.A., at 4727 Sunbeam Rd, Jacksonville, FL 32257 in Duval County. The practice phone is (904) 880-0622.

Dr. Pentel's primary practice is Southside Dermatology, P.A. in Jacksonville, Florida. The medical group on file is VitalMD. Dmand AI also links Dr. Pentel to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pentel practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Pentel's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Pentel is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Pentel's licenses on file in 2 states: Florida and Rhode Island.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes and psoriasis among the conditions Dr. Pentel treats.

CMS data shows 17,281 Medicare services from Dr. Pentel across 39 procedure codes in 2024, for 454 Medicare patients. Medicare paid $503,285 for them. Every service was in an office.

CMS counts 454 Medicare patients who saw Dr. Pentel in 2024. The largest group is 65 to 74, with 227 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pentel's median patient age at 66, with 60% women.

In 2024, Dr. Pentel wrote 236 Medicare Part D claims for 140 patients. 99% of them were for generic drugs. CMS names the drug for 183 of them, across 6 drugs with 11 or more claims each, at $1,630 in total drug cost. In 2023, CMS named 112 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Pentel for performance year 2024, reported individually. Dr. Pentel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 481 procedures of skin biopsy by Dr. Pentel, more than 95% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Pentel.

CMS Open Payments shows 903 general payments to Dr. Pentel from 53 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Galderma Laboratories, L.P. paid the most, $37,980.

Dmand AI lists 2 awards for Dr. Pentel.

Dr. Pentel graduated from Penn State College of Medicine in 1994. Dr. Pentel is a member of AAD and ASDS.

Dr. Pentel is in network with 16 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.